Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry
© 2016 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd Aim: To evaluate and compare the retention rate of biological disease-modifying antirheumatic drugs (bDMARDs) in real-life practice and identify risk factors related to remission and drug discontin...
Saved in:
Main Authors: | Pongthorn Narongroeknawin, Parawee Chevaisrakul, Nuntana Kasitanon, Tasanee Kitumnuaypong, Ajanee Mahakkanukrauh, Boonjing Siripaitoon, Wanruchada Katchamart |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84996602311&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/59055 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry
by: Pongthorn Narongroeknawin, et al.
Published: (2019) -
Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor Therapies in Patients with Spondyloarthritis: Analysis from the Thai Rheumatic Disease Prior Authorization Registry
by: Praveena Chiowchanwisawakit, et al.
Published: (2019) -
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
by: Worawit Louthrenoo, et al.
Published: (2018) -
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
by: Worawit Louthrenoo, et al.
Published: (2018) -
Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis
by: Wanruchada Katchamart, et al.
Published: (2020)